How do you approach a patient who responded to first line osimertinib but develop an isolated progressing lesion that retains sensitizing EGFR mutation but develops MET amplification?
1 Answers
Mednet Member
Medical Oncology · University of Colorado Cancer Center
Radiate single site and continue OSI. Repeat liquid biopsy at next progression.
